Blog
RSS FeedPosted by Michael Wonder on 23 Apr 2024
New recommendations to strengthen supply chains of critical medicines
23 April 2024 - EMA has published a number of recommendations to address vulnerabilities in the production and delivery of medicines ...
Posted by Michael Wonder on 24 Feb 2024
Shortage of migraine medication crushing for chronic pain patients
23 February 2024 - A migraine medication shortage has spread across the country, threatening to leave tens of thousands of ...
Posted by Michael Wonder on 13 Dec 2023
First version of the Union list of critical medicines agreed to help avoid potential shortages in the EU
12 December 2023 - The European Commission, the Heads of Medicines Agencies and EMA have published the first version of the ...
Posted by Michael Wonder on 13 Nov 2023
Novo Nordisk to discontinue Levemir insulin in US market
8 November 2023 - Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, ...
Posted by Michael Wonder on 04 Nov 2023
Hormone replacement therapy patch shortages are having a big impact on the women who need them
4 November 2023 - Women are being thrust back into the most severe stages of menopause amid long-running national shortages of ...
Posted by Michael Wonder on 03 Nov 2023
Mounjaro (tirzepatide), the first and only single molecule GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes is now available in Canada
2 November 2023 - Mounjaro represents the first new class of diabetes medicines introduced in nearly a decade and is now ...
Posted by Michael Wonder on 24 Oct 2023
EMA takes further steps to address critical shortages of medicines in the EU
24 October 2023 - Today, the EMA published details of the newly created solidarity mechanism developed by the EMA Medicines Shortages ...
Posted by Michael Wonder on 07 Oct 2023
Cancer drug shortage eases slightly, but it’s still ‘living from paycheck to paycheck’
5 October 2023 - The shortage of cancer drugs is not going away, but it may be easing slightly, a ...
Posted by Michael Wonder on 24 Sep 2023
New rules for weight loss ‘wonder drug’ after regulator clamp down
23 September 2023 - Australia’s pharmaceuticals regulator has ushered in new rules for a diabetes drug, which is being hailed by ...
Posted by Michael Wonder on 21 Sep 2023
Supply and insurance issues snarl fall COVID-19 vaccine campaign for some
20 September 2023 - It has been just over a week since the US FDA and the US Centers for ...
Posted by Michael Wonder on 07 Sep 2023
Ozempic and Wegovy maker ‘just scratching the surface’ in meeting demand for weight loss drugs, CEO says
5 September 2023 - It could take years before Novo Nordisk has fulfilled demand for its highly popular weight loss ...
Posted by Michael Wonder on 24 Aug 2023
Cancer treatment uncertainty: European nations struggle with drug shortages
21 August 2023 - Experts in Europe detail the challenge with current cancer drug shortages and how regulators are trying ...
Posted by Michael Wonder on 16 Aug 2023
The collateral damage of ADHD drug shortages
15 August 2023 - As a new school year begins, parents and doctors find medication shortages are leading to declines in ...
Posted by Michael Wonder on 09 Aug 2023
Public pharma is the best solution to the on-going problem of drug shortages
9 August 2023 - Drug shortages in the United States are at a record high. At least 14 essential generic ...
Posted by Michael Wonder on 17 Jul 2023
European Health Union: EU steps up action to prevent shortages of antibiotics for next winter
17 July 2023 - The European Commission, the Heads of Medicines Agencies and the European Medicines Agency are today issuing recommendations ...